Skip to main navigation Skip to search Skip to main content

Increased expression of ABCG2 (BCRP) promotes adaptive resistance to niraparib in novel clinically relevant models of treatment resistant ovarian cancer

Activity: Talk or presentation types › Invited talk

Description

Molecular Determinants of Cancer Therapy Resistance - IRB Barcelona BioMed conference
Period18 Nov 2024 → 20 Nov 2024
Event titleMolecular Determinants of Cancer Therapy Resistance - IRB BioMed Conference series
Event typeConference
LocationBarcelona, SpainShow on map
Degree of RecognitionInternational